atorvastatin has been researched along with Hepatitis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| García Pajares, F; Maroto-Martín, C; Molina Terrón, PM | 1 |
| Abd-Rabo, MM; Ahmed, IS; El Hosary, R; Wahman, LF | 1 |
| Chen, Y; Duan, Y; Han, J; Li, Q; Li, X; Li, Y; Liu, Y; Ma, C; Sun, L; Tan, H; Wang, Y; Yang, X; Zhao, B | 1 |
| Alegret, M; Ađalsteisson, GS; Laguna, JC; Merlos, M; Rebollo, A; Roglans, N; Vilà, L | 1 |
| Hassanian, MA; Samy, W | 1 |
| Adim, SB; Dolar, E; Gulten, M; Gurel, S; Kiyici, M; Memik, F; Nak, SG; Savci, G; Yerci, O | 1 |
| Georgescu, EF; Georgescu, M | 1 |
| Gao, Y; Ge, GY; Jia, YJ; Jiang, MN; Song, LX | 1 |
| Mandó, OG; Ridruejo, E | 1 |
3 trial(s) available for atorvastatin and Hepatitis
| Article | Year |
|---|---|
Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
Topics: Adult; Alanine Transaminase; Anticholesteremic Agents; Aryldialkylphosphatase; Aspartate Aminotransferases; Atorvastatin; Cholesterol; Cross-Sectional Studies; Disease Progression; Fatty Liver; Female; Glutathione Peroxidase; Hepatitis; Heptanoic Acids; Humans; Lipid Peroxidation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Pyrroles; Risk Factors; Triglycerides | 2011 |
Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Fatty Liver; Female; Hepatitis; Heptanoic Acids; Humans; Male; Middle Aged; Prospective Studies; Pyrroles; Ursodeoxycholic Acid | 2003 |
Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.
Topics: Adult; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Cholagogues and Choleretics; Fatty Liver; Female; Hematologic Agents; Hepatitis; Heptanoic Acids; Humans; Losartan; Male; Middle Aged; Pentoxifylline; Pyrroles; Treatment Outcome; Ursodeoxycholic Acid | 2007 |
6 other study(ies) available for atorvastatin and Hepatitis
| Article | Year |
|---|---|
Atorvastatin-induced acute cholestatic hepatitis.
Topics: Acute Disease; Atorvastatin; Chemical and Drug Induced Liver Injury; Cholestasis; Hepatitis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2022 |
High-fat diet induced alteration in lipid enzymes and inflammation in cardiac and brain tissues: Assessment of the effects of Atorvastatin-loaded nanoparticles.
Topics: Acyl Coenzyme A; Animals; Atorvastatin; Brain; Cholesterol 7-alpha-Hydroxylase; Cytokines; Diet, High-Fat; Drug Delivery Systems; Encephalitis; Hepatitis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocarditis; Nanoparticles; Rats; Receptors, LDL; Treatment Outcome | 2020 |
NaoXinTong Enhances Atorvastatin-induced Plaque Stability While Ameliorating Atorvastatin-induced Hepatic Inflammation.
Topics: Animals; Atorvastatin; Drug Synergism; Drug Therapy, Combination; Drugs, Chinese Herbal; Hepatitis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic | 2017 |
Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment.
Topics: Animals; Atorvastatin; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cyclic AMP-Dependent Protein Kinases; Dietary Carbohydrates; Disease Models, Animal; Down-Regulation; Fatty Acids; Fatty Liver; Fructokinases; Fructose; Gene Expression Regulation; Hepatitis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; I-kappa B Proteins; Inflammation Mediators; Lipid Metabolism; Liver; Male; Metallothionein; Necrosis; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Phosphorylation; Pyrroles; Rats; Rats, Sprague-Dawley; Triglycerides | 2011 |
Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
Topics: Acute-Phase Proteins; Alanine Transaminase; Animals; Atorvastatin; Carrier Proteins; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drugs, Chinese Herbal; Endotoxins; Fatty Liver; Hepatitis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Interleukin-1beta; Lipids; Lipopolysaccharide Receptors; Liver; Lymphocyte Antigen 96; Male; Membrane Glycoproteins; NF-kappa B; Nitric Oxide Synthase Type II; Polymerase Chain Reaction; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Immunologic; RNA, Messenger; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2008 |
Acute cholestatic hepatitis after reinitiating treatment with atorvastatin.
Topics: Acute Disease; Aged; Atorvastatin; Cholestasis; Hepatitis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles | 2002 |